John Lamont
John Lamont
Professor of Medicine, Harvard Medical School
Verified email at bidmc.harvard.edu
Title
Cited by
Cited by
Year
Clostridium difficile — More Difficult Than Ever
CP Kelly, JT LaMont
New England Journal of Medicine 359 (18), 1932-1940, 2008
15912008
Clostridium difficile colitis
CP Kelly, C Pothoulakis, JT LaMont
New England Journal of Medicine 330 (4), 257-262, 1994
15151994
Clostridium difficile Infection
DA Leffler, JT Lamont
New England Journal of Medicine 372 (16), 1539-1548, 2015
9592015
Choline, an essential nutrient for humans
SH Zeisel, KA Da Costa, PD Franklin, EA Alexander, JT Lamont, ...
The FASEB journal 5 (7), 2093-2098, 1991
5821991
Clostridium difficile Infection
CP Kelly, JT LaMont
Annual review of medicine 49 (1), 375-390, 1998
5661998
Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa
I Castagliuolo, MF Riegler, L Valenick, JT LaMont, C Pothoulakis
Infection and immunity 67 (1), 302-307, 1999
5081999
Role of Gallbladder Mucus Hypersecretion in the Evolution of Cholesterol Gallstones: STUDIES IN THE PRAIRIE DOG
SP Lee, JT Lamont, MC Carey
The Journal of clinical investigation 67 (6), 1712-1723, 1981
4371981
Mucin biophysics
R Bansil, E Stanley, JT LaMont
Annual review of physiology 57 (1), 635-657, 1995
4361995
Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers.
G Hecht, C Pothoulakis, JT LaMont, JL Madara
The Journal of clinical investigation 82 (5), 1516-1524, 1988
4251988
Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.
M Riegler, R Sedivy, C Pothoulakis, G Hamilton, J Zacherl, G Bischof, ...
The Journal of clinical investigation 95 (5), 2004-2011, 1995
3951995
Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum
C Pothoulakis, CP Kelly, MA Joshi, N Gao, CJ O'Keane, I Castagliuolo, ...
Gastroenterology 104 (4), 1108-1115, 1993
3621993
Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin
DYM Leung, CP Kelly, M Boguniewicz, C Pothoulakis, JT LaMont, ...
The Journal of pediatrics 118 (4), 633-637, 1991
3311991
Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells
I Castagliuolo, JT Lamont, B Qiu, SM Fleming, KR Bhaskar, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 271 (5 …, 1996
3111996
Intravenous immunoglobulin therapy for severe Clostridium difficile colitis
J Salcedo, S Keates, C Pothoulakis, M Warny, I Castagliuolo, JT LaMont, ...
Gut 41 (3), 366-370, 1997
3051997
Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.
I Castagliuolo, JT LaMont, ST Nikulasson, C Pothoulakis
Infection and immunity 64 (12), 5225-5232, 1996
2961996
CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.
C Pothoulakis, I Castagliuolo, JT Lamont, A Jaffer, JC O'Keane, ...
Proceedings of the National Academy of Sciences 91 (3), 947-951, 1994
2921994
Saccharomyces boulardii stimulates intestinal immunoglobulin a immune response to clostridium difficiletoxin a in mice
A Qamar, S Aboudola, M Warny, P Michetti, C Pothoulakis, JT LaMont, ...
Infection and immunity 69 (4), 2762-2765, 2001
2852001
Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life
S Jangi, JT Lamont
Journal of pediatric gastroenterology and nutrition 51 (1), 2-7, 2010
2722010
Aspirin prevention of cholesterol gallstone formation in prairie dogs
SP Lee, MC Carey, JT LaMont
Science 211 (4489), 1429-1431, 1981
2651981
Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile
PF Levy, BF Smith, JT LaMont
Gastroenterology 87 (2), 270-275, 1984
2541984
The system can't perform the operation now. Try again later.
Articles 1–20